The Pennsylvania measles death toll rose after a 40-year-old woman in Jefferson County died from complications associated with the disease. The Jefferson County coroner’s office reported that the woman died Saturday. The office said it is working with the Pennsylvania Department of Health on the case. Coroner Greg Furlong described the death as a heartbreaking… Continue reading Pennsylvania Measles Death: Woman Dies From Complications
The DR Congo Ebola outbreak has surpassed 7,000 recorded cases, making it the largest Ebola epidemic ever reported in the Democratic Republic of Congo. Congolese authorities reported 7,022 cases, including 3,398 deaths and 1,671 recoveries. The outbreak has also spread to a seventh province, adding to concerns about continued transmission. However, there are some signs… Continue reading DR Congo Ebola Outbreak Passes 7,000 Cases
Tylenol maker Kenvue is asking a U.S. appeals court to reconsider its decision to revive more than 500 lawsuits alleging that the painkiller may be linked to autism and ADHD. Kenvue joined major retailers and pharmacy operators in filing the request with the 2nd U.S. Circuit Court of Appeals in Manhattan. The companies want the… Continue reading Tylenol Autism Lawsuits: Kenvue Seeks Court Reconsideration
Vaccine hesitancy in wealthy countries has made global measles eradication unrealistic for now, Microsoft co-founder and philanthropist Bill Gates told Reuters. Gates said his foundation once considered measles eradication a possible long-term goal. However, growing doubts about vaccines in richer nations have changed that outlook. “At one point, the foundation wanted to eradicate measles,” Gates… Continue reading Vaccine Hesitancy Threatens Global Measles Fight
BioNTech says its experimental cancer drug gotistobart has significantly extended survival in patients with a difficult-to-treat form of lung cancer. The company reported the findings from the PRESERVE-003 Phase 3 trial on Monday. The study examined patients with metastatic squamous non-small cell lung cancer, or NSCLC, whose disease progressed after earlier immunotherapy and chemotherapy. According… Continue reading Gotistobart Lung Cancer: Trial Shows Survival Benefit
U.S. cancer centers are facing shortages of critical medicines, putting added pressure on hospitals and oncology teams. A recent survey from the National Comprehensive Cancer Network (NCCN) highlights the scale of the problem. The group surveyed pharmacy directors and other clinical and administrative leaders at its 34 member institutions in late August. Of the 31… Continue reading US Cancer Drug Shortages Hit Hospitals Nationwide
A new type of eye drop could help people who struggle to see clearly while driving at night. Opus Genetics reported encouraging results from late-stage studies of phentolamine ophthalmic solution 0.75%. The treatment improved several measures of vision in dim and dark conditions. The company is developing the drops for people with chronic night-driving problems… Continue reading Night Vision Eye Drops: Trials Show Better Driving Vision
Novo Nordisk’s blockbuster weight-loss drug Wegovy has received approval in China for the treatment of metabolic dysfunction-associated steatohepatitis, known as MASH. The Danish drugmaker announced the decision on Thursday. It marks a major expansion for Wegovy beyond weight management. According to Novo Nordisk, Wegovy is the first GLP-1 receptor agonist approved in China for MASH.… Continue reading Wegovy MASH: China Approves Drug for Liver Disease
AstraZeneca said its cancer drug Imfinzi, combined with Amgen’s Imdelltra, significantly improved overall survival for patients with extensive-stage small-cell lung cancer. The companies reported the results from the late-stage DeLLphi-305 trial on Tuesday. The study tested the combination as a maintenance treatment after patients completed initial therapy with Imfinzi and platinum chemotherapy. The findings could… Continue reading Imfinzi Imdelltra Combo Shows Lung Cancer Survival Benefit
Dow University of Health Sciences (DUHS) will establish a Basic Life Support (BLS) training center in Larkana under a new partnership with Shaheed Mohtarma Benazir Bhutto Medical University (SMBBMU). The two universities signed a memorandum of understanding (MoU) to expand access to certified lifesaving training in Larkana and upper Sindh. Officials signed the agreement at… Continue reading Larkana BLS Center: DUHS to Expand Life Support Training
